EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Convergent Renal Insult: Why Endurance Athletes’ Self‐Medication With Nonsteroidal Anti‐Inflammatory Drugs Requires a Sport‐Specific Risk Model—A Narrative Review From Pharmaceutical and Sport‐Science Perspectives

Andreas Will iD

Translational Sports Medicine · 2026-01 · 2026 (1)

DOI: 10.1155/tsm2/8716858 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Translational Sports Medicine, online erschienen am 16.11.2026. Verfasst von Andreas Will. Beteiligte Einrichtung: Department Health and Sport Sciences TUM School of Medicine and Health Technical University of Munich Am Olympiacampus 11 Munich 80809 Germany tum.de. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nonsteroidal anti‐inflammatory drugs (NSAIDs) are the most widely consumed pharmacological agents in endurance sport, with reported prevalence of 14.8%–88% and consumption dominated by prophylactic rather than therapeutic intent despite three meta‐analyses demonstrating no ergogenic effect. This use is sustained by a decision architecture in which pain is reframed as a controllable barrier to performance, prophylactic dosing is normalized within the training group, and renal risk is systematically underestimated: Among IRONMAN triathletes, only 27% were aware of it. This narrative review reframes the safety problem around the kidney. During prolonged high‐intensity exercise, three stressors converge: sympathetic renal vasoconstriction, progressive dehydration activating the renin–angiotensin–aldosterone system, and NSAID‐mediated prostaglandin inhibition, removing the compensatory vasodilatory safety net. This sport‐specific convergent renal insult differs structurally from the clinical triple whammy because the first two stressors are intrinsic to the activity itself. The clinical manifestation appears intensity‐ and duration‐dependent: Ibuprofen increased acute kidney injury rates from 34% to 52% during an 80‐km ultramarathon stage (NNH 5.5; not statistically significant) but did not amplify biomarker responses during one hour of moderate running. Whether repeated transient insults accumulate into chronic kidney disease, as established for occupational heat‐stress nephropathy and for hospital‐documented AKI, remains the central unanswered question for habitual athletic NSAID users. Among the guideline documents reviewed, none currently addresses habitual over‐the‐counter NSAID use under exercise‐induced renal stress in healthy athletes. The epidemiology and decision architecture of repeated exposure, the renal evidence base, the cumulative‐exposure question, and the gap in current guidance together define future research needs for endurance‐sport analgesic pharmacovigilance.

Schlagwörter

Stichwörter der Autor:innen

NSAIDacute kidney injurychronic kidney diseasecommunity pharmacyendurance sportguideline gapself-medication

Autor:innen und Institutionen

  • Department Health and Sport Sciences TUM School of Medicine and Health Technical University of Munich Am Olympiacampus 11 Munich 80809 Germany tum.de.

ORCID-Profile: Andreas Will

Zitieren

APA

Will, A. (2026). The Convergent Renal Insult: Why Endurance Athletes’ Self‐Medication With Nonsteroidal Anti‐Inflammatory Drugs Requires a Sport‐Specific Risk Model—A Narrative Review From Pharmaceutical and Sport‐Science Perspectives. Translational Sports Medicine, 2026(1). https://doi.org/10.1155/tsm2/8716858

Vancouver

Will A. The Convergent Renal Insult: Why Endurance Athletes’ Self‐Medication With Nonsteroidal Anti‐Inflammatory Drugs Requires a Sport‐Specific Risk Model—A Narrative Review From Pharmaceutical and Sport‐Science Perspectives. Translational Sports Medicine. 2026;2026(1). doi:10.1155/tsm2/8716858

BibTeX
@article{Will2026,
  author = {Will, Andreas},
  title = {The Convergent Renal Insult: Why Endurance Athletes’ Self‐Medication With Nonsteroidal Anti‐Inflammatory Drugs Requires a Sport‐Specific Risk Model—A Narrative Review From Pharmaceutical and Sport‐Science Perspectives},
  journal = {Translational Sports Medicine},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/tsm2/8716858}
}
Kostenlos starten →